Skip to main content
EMBC
NASDAQ Industrial Applications And Services

Embecta's Q3 Beat and Raised Guidance Signal a Turnaround After a Disastrous Q2

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.89
Mkt Cap
$207.647M
52W Low
$2.77
52W High
$15.55
52W Position info
40% above low
Off High info
75% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

EMBC sits 40% above its 52-week low of $2.77.

Summary

Embecta reported Q3 adjusted EPS of $0.56, beating expectations and raising full-year guidance for adjusted operating margin and EPS. The results mark a sharp sequential improvement from a disastrous Q2, driven by revenue recovery, the Owen Mumford acquisition, and debt reduction.


Key Events · Earnings and Guidance · EMBC

  • Q3 Adjusted EPS Beat

    Adjusted EPS of $0.56 significantly exceeded the backdrop of a disastrous Q2, when the company posted a net loss and slashed guidance.

  • Full-Year Guidance Raised

    FY26 adjusted operating margin guidance was raised to 23.50%–24.00% (from 22.25%–23.25%) and adjusted EPS to $1.80–$1.90 (from $1.55–$1.75), while revenue guidance was reaffirmed at $1,015–$1,035 million.

  • Sequential Revenue Rebound

    Q3 revenues of $271.7 million were up ~$50 million sequentially, driven by improved U.S. and international performance and a partial quarter contribution from the Owen Mumford acquisition.

  • Debt Repayment and Share Buybacks

    The company repaid ~$53 million of debt during the quarter and repurchased ~$9 million of shares under the $100 million buyback program, strengthening the balance sheet.


Analysis · EMBC · Industrial Applications And Services

A much-needed beat arrived in Q3, with adjusted EPS of $0.56 handily topping the backdrop of a disastrous Q2 miss. The company raised its full-year adjusted operating margin and EPS guidance, signaling that the worst may be over. The quarter benefited from a sequential revenue rebound of ~$50 million, contributions from the Owen Mumford acquisition, and progress on debt repayment and share buybacks. While U.S. revenues remain under pressure, international growth and GLP-1 co-packaging launches in Canada and Brazil provide new growth vectors. The raised guidance and improved balance sheet actions suggest management is regaining control after a turbulent first half.

At the time of this filing, EMBC was trading at $3.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $207.6M. The 52-week trading range was $2.77 to $15.55. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EMBC - Latest Insights

EMBC
Aug 07, 2026, 6:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.65
Real-time Price: $3.89 info
Change: +$0.2385 (+7%) info
Market Cap: $207.647M info
EMBC
Jul 31, 2026, 4:35 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $3.59
Real-time Price: $3.89 info
Change: +$0.2985 (+8%) info
Market Cap: $207.647M info
EMBC
Jun 23, 2026, 11:52 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $3.08
Real-time Price: $3.89 info
Change: +$0.8135 (+26%) info
Market Cap: $207.647M info
EMBC
May 15, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.13
Real-time Price: $3.89 info
Change: +$0.7635 (+24%) info
Market Cap: $207.647M info
EMBC
May 15, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.12
Real-time Price: $3.89 info
Change: +$0.7676 (+25%) info
Market Cap: $207.647M info